A transcriptomic biomarker predictive of cell proliferation for use in adverse outcome pathway-informed testing and assessment

J Christopher Corton, Victoria Ledbetter, Samuel M Cohen, Ella Atlas, Carole L Yauk and Jie Liu

Toxicological Sciences, 2024, 201, 174
DOI: 10.1093/toxsci/kfae102

Incorporating lines of evidence from New Approach Methodologies (NAMs) to reduce uncertainties in a category based read-across: A case study for repeated dose toxicity

Cynthia B. Pestana, James W. Firman and Mark T.D. Cronin

Regulatory Toxicology and Pharmacology, 2021, 120, 104855
DOI: 10.1016/j.yrtph.2020.104855

Diazepam Promotes Translocation of Human Constitutive Androstane Receptor (CAR) via Direct Interaction with the Ligand-Binding Domain

Josef Skoda, Jan Dusek, Martin Drastik, Alzbeta Stefela, Klara Dohnalova, Karel Chalupsky, Tomas Smutny, Stanislav Micuda, Sabine Gerbal-Chaloin and Petr Pavek

Cells, 2020, 9, 2532
DOI: 10.3390/cells9122532

Application of transcriptomic and microRNA profiling in the evaluation of potential liver carcinogens

Vicky Nicolaidou and Costas Koufaris

Toxicol Ind Health, 2020, 36, 386
DOI: 10.1177/0748233720922710

Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR

Jenni Küblbeck, Jonna Niskanen and Paavo Honkakoski

Cells, 2020, 9, 2306
DOI: 10.3390/cells9102306

The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation

Tomoya Yamada, Samuel M. Cohen and Brian G. Lake

Critical Reviews in Toxicology, 2025, 55, 549
DOI: 10.1080/10408444.2025.2513332

Stilbene compound trans-3,4,5,4´-tetramethoxystilbene, a potential anticancer drug, regulates constitutive androstane receptor (Car) target genes, but does not possess proliferative activity in mouse liver

Jan Dusek, Josef Skoda, Ondrej Holas, Alzbeta Horvatova, Tomas Smutny, Lenka Linhartova, Petra Hirsova, Otto Kucera, Stanislav Micuda, Albert Braeuning and Petr Pavek

Toxicology Letters, 2019, 313, 1
DOI: 10.1016/j.toxlet.2019.05.024

Piperonyl butoxide: Mode of action analysis for mouse liver tumour formation and human relevance

Brian G. Lake, Roger J. Price, Mary P. Scott, Lynsey R. Chatham, Audrey Vardy and Thomas G. Osimitz

Toxicology, 2020, 439, 152465
DOI: 10.1016/j.tox.2020.152465

The Cell Transformation Assay: A Historical Assessment of Current Knowledge of Applications in an Integrated Approach to Testing and Assessment for Non-Genotoxic Carcinogens

Annamaria Colacci, Raffaella Corvi, Kyomi Ohmori, Martin Paparella, Stefania Serra, Iris Da Rocha Carrico, Paule Vasseur and Miriam Naomi Jacobs

IJMS, 2023, 24, 5659
DOI: 10.3390/ijms24065659

Promotor effect of S-metolachlor generics with different hepatotoxicity in liver carcinogenesis in rats

E.A. Bagley, N.M. Nedopytanska, V.S. Lisovska, O.V. Reshavska and L.V. Tkachenko

UJMTA, 2019, 86, 5
DOI: 10.33273/2663-4570-2019-86-2-5-13

Application of humanized mice to toxicology studies: Evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)

Tomoya Yamada

J Toxicol Pathol, 2021, 34, 283
DOI: 10.1293/tox.2021-0027

Clinical Relevance of the Constitutive Androstane Receptor

Sydney Stern, Ritika Kurian and Hongbing Wang

Drug Metabolism and Disposition, 2022, 50, 1010
DOI: 10.1124/dmd.121.000483

Evaluation of the human hazard of the liver and lung tumors in mice treated with permethrin based on mode of action

Tomoya Yamada, Brian G. Lake and Samuel M. Cohen

Critical Reviews in Toxicology, 2022, 52, 1
DOI: 10.1080/10408444.2022.2035316

Analysis of β-catenin gene mutations and gene expression in liver tumours of C57BL/10J mice produced by chronic administration of sodium phenobarbital

James E. Sidaway, Terry C. Orton, Kassiani Kalaitzi, Huw B. Jones, Alison Foster and Brian G. Lake

Toxicology, 2020, 430, 152343
DOI: 10.1016/j.tox.2019.152343

Comparison of the Hepatic Effects of Phenobarbital in Chimeric Mice Containing Either Rat or Human Hepatocytes With Humanized Constitutive Androstane Receptor and Pregnane X Receptor Mice

Tomoya Yamada, Ayako Ohara, Naoya Ozawa, Keiko Maeda, Miwa Kondo, Yu Okuda, Jun Abe, Samuel M Cohen and Brian G Lake

Toxicological Sciences, 2020, 177, 362
DOI: 10.1093/toxsci/kfaa125

CAR requires Gadd45β to promote phenobarbital-induced mouse liver tumors in early stage

Takeshi Hori, Kosuke Yokobori, Rick Moore, Masahiko Negishi and Tatsuya Sueyoshi

Front. Oncol., 2023, 13
DOI: 10.3389/fonc.2023.1217847

Combining In Vivo and Organotypic In Vitro Approaches to Assess the Human Relevance of Basimglurant (RG7090), a Potential CAR Activator

Ramona Nudischer, Kasper Renggli, Cristina Bertinetti-Lapatki, Jean-Christophe Hoflack, Nicholas Flint, Sabine Sewing, Lykke Pedersen, Simone Schadt, Larry G Higgins, Audrey Vardy, Barbara Lenz, Laurent Gand, Franziska Boess, Barbara M Elcombe, Andreas Hierlemann and Adrian B Roth

Toxicological Sciences, 2020, 176, 329
DOI: 10.1093/toxsci/kfaa076

Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer

Sarah Da Won Bae, Romario Nguyen, Lawrence Yuen, Vincent Lam, Jacob George and Liang Qiao

Sci Rep, 2024, 14
DOI: 10.1038/s41598-024-81571-z

Carboxylesterases: Pharmacological Inhibition Regulated Expression and Transcriptional Involvement of Nuclear Receptors and other Transcription Factors

Yuanjun Shen, Zhanquan Shi and Bingfang Yan

Nuclear Receptor Research, 2019, 6
DOI: 10.32527/2019/101435

A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per‐ and polyfluoroalkyl substances and relevance to human health

John M. Rogers, Melissa M. Heintz, Chad M. Thompson and Laurie C. Haws

Birth Defects Research, 2023, 115, 1011
DOI: 10.1002/bdr2.2185

Myclobutanil-mediated alteration of liver-gut FXR signaling in mice

Rulaiha Taylor, Laura Armstrong, Anisha Bhattacharya, Zakiyah Henry, Anita Brinker, Brian Buckley, Bo Kong and Grace Guo

Toxicological Sciences, 2023, 191, 387
DOI: 10.1093/toxsci/kfac129

Suppression of apoptotic signaling in rat hepatocytes by non-dioxin-like polychlorinated biphenyls depends on the receptors CAR and PXR

Maike Gährs and Dieter Schrenk

Toxicology, 2021, 464, 153023
DOI: 10.1016/j.tox.2021.153023

Searching for Constitutive Androstane Receptor Modulators

Paavo Honkakoski

Drug Metabolism and Disposition, 2022, 50, 1002
DOI: 10.1124/dmd.121.000482

Constitutive androstane receptor (CAR) mediates dieldrin-induced liver tumorigenesis in mouse

Zemin Wang, Qiangen Wu, Xilin Li and James E. Klaunig

Arch Toxicol, 2020, 94, 2873
DOI: 10.1007/s00204-020-02781-8

Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver

Heike Sprenger, Josef Daniel Rasinger, Helen Hammer, Wael Naboulsi, Elke Zabinsky, Hannes Planatscher, Michael Schwarz, Oliver Poetz and Albert Braeuning

Arch Toxicol, 2022, 96, 2739
DOI: 10.1007/s00204-022-03338-7

Toxicological evaluation of carcinogenicity of the pyrethroid imiprothrin in rats and mice

Tomoya Yamada, Hiroyuki Asano, Kaori Miyata, Lorenz R. Rhomberg, Joseph K. Haseman, Peter Greaves, Helmut Greim, Colin Berry and Samuel M. Cohen

Regulatory Toxicology and Pharmacology, 2019, 105, 1
DOI: 10.1016/j.yrtph.2019.03.012

Role of the constitutive androstane receptor (CAR) in human liver cancer

Sarah Da Won Bae, Romario Nguyen, Liang Qiao and Jacob George

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021, 1875, 188516
DOI: 10.1016/j.bbcan.2021.188516

A retrospective study on EU harmonised classifications for carcinogenicity to guide future research

Claire Terry, Zhongyu Yan, Marco Corvaro and Sean C. Gehen

Regulatory Toxicology and Pharmacology, 2021, 119, 104800
DOI: 10.1016/j.yrtph.2020.104800

Interactions of Betel Quid Constituents with Drug Disposition Pathways: An Overview

Jasmine Canlas and Alan L. Myers

CDM, 2023, 24, 92
DOI: 10.2174/1389200224666230228142052

Widespread Epigenetic Changes to the Enhancer Landscape of Mouse Liver Induced by a Specific Xenobiotic Agonist Ligand of the Nuclear Receptor CAR

Andy Rampersaud, Nicholas J Lodato, Aram Shin and David J Waxman

Toxicological Sciences, 2019, 171, 315
DOI: 10.1093/toxsci/kfz148

Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications

Daniel Desaulniers, Paule Vasseur, Abigail Jacobs, M. Cecilia Aguila, Norman Ertych and Miriam N. Jacobs

IJMS, 2021, 22, 10969
DOI: 10.3390/ijms222010969

Weight of evidence and human relevance evaluation of the benfluralin mode of action in rodents (Part I): Liver carcinogenesis

Christian Strupp, Nicolas Quesnot, Lysiane Richert, Joanna Moore, Werner H. Bomann and Pramila Singh

Regulatory Toxicology and Pharmacology, 2020, 117, 104758
DOI: 10.1016/j.yrtph.2020.104758

Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)

Tomoya Yamada, Samuel M. Cohen and Brian G. Lake

Critical Reviews in Toxicology, 2021, 51, 373
DOI: 10.1080/10408444.2021.1939654

Mode of action analysis for fluxapyroxad-induced rat liver tumour formation: evidence for activation of the constitutive androstane receptor and assessment of human relevance

Manuela Goettel, Christoph Werner, Naveed Honarvar, Sibylle Gröters, Ivana Fegert, Corinne Haines, Lynsey R. Chatham, Audrey Vardy and Brian G. Lake

Toxicology, 2024, 505, 153828
DOI: 10.1016/j.tox.2024.153828

Unraveling Human Hepatocellular Responses to PFAS and Aqueous Film-Forming Foams (AFFFs) for Molecular Hazard Prioritization and In Vivo Translation

Kevin A. Mauge-Lewis, Sreenivasa C. Ramaiahgari, Scott S. Auerbach, Georgia K. Roberts, Suramya Waidyanatha, Suzanne E. Fenton, Dhiral P. Phadke, Michele R. Balik-Meisner, Arpit Tandon, Deepak Mav, Brian Howard, Ruchir Shah, Barney Sparrow, Jenni Gorospe and Stephen S. Ferguson

Environ. Sci. Technol., 2025, 59, 2423
DOI: 10.1021/acs.est.4c10595

Club Cells Are the Primary Target for Permethrin-Induced Mouse Lung Tumor Formation

Keiko Ogata, Yang Liu, Ayako Ohara, Kensuke Kawamoto, Miwa Kondo, Kumiko Kobayashi, Takako Fukuda, Hiroyuki Asano, Sachiko Kitamoto, Brian G Lake, Samuel M Cohen and Tomoya Yamada

Toxicological Sciences, 2021, 184, 15
DOI: 10.1093/toxsci/kfab103

Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation

Mark E. Mazin, Andrei A. Yarushkin, Yuliya A. Pustylnyak, Elena A. Prokopyeva and Vladimir O. Pustylnyak

Mol Biol Rep, 2022, 49, 4089
DOI: 10.1007/s11033-022-07340-1

Risk assessment of chlorinated paraffins in feed and food

Dieter Schrenk, Marguerita Bignami, Laurent Bodin, James Kevin Chipman, Jesús del Mazo, Bettina Grasl‐Kraupp, Christer Hogstrand, Laurentius (Ron) Hoogenboom, Jean‐Charles Leblanc, Carlo Stefano Nebbia, Evangelia Ntzani, Annette Petersen, Salomon Sand, Tanja Schwerdtle, Christiane Vleminckx, Heather Wallace, Beat Brüschweiler, Pim Leonards, Martin Rose, Marco Binaglia, Zsuzsanna Horváth, Luisa Ramos Bordajandi and Elsa Nielsen

EFS2, 2020, 18
DOI: 10.2903/j.efsa.2020.5991

Mechanisms of hepatic cancer by persistent organic pollutants

James E. Klaunig, Luma Melo and Karen Tilmant

Current Opinion in Toxicology, 2020, 19, 105
DOI: 10.1016/j.cotox.2020.02.001

The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them

Martyn T. Smith, Kathryn Z. Guyton, Nicole Kleinstreuer, Alexandre Borrel, Andres Cardenas, Weihsueh A. Chiu, Dean W. Felsher, Catherine F. Gibbons, William H. Goodson, Keith A. Houck, Agnes B. Kane, Michele A. La Merrill, Herve Lebrec, Leroy Lowe, Cliona M. McHale, Sheroy Minocherhomji, Linda Rieswijk, Martha S. Sandy, Hideko Sone, Amy Wang, Luoping Zhang, Lauren Zeise and Mark Fielden

Cancer Epidemiology, Biomarkers & Prevention, 2020, 29, 1887
DOI: 10.1158/1055-9965.EPI-19-1346

Reevaluation of Hepatocellular Neoplasms in CD-1 Mice from a 2-year Oral Carcinogenicity Study with Permethrin

Erin M. Quist, Gary A. Boorman, John M. Cullen, Robert R. Maronpot, Amera K. Remick, James A. Swenberg, Les Freshwater and Jerry F. Hardisty

Toxicol Pathol, 2019, 47, 11
DOI: 10.1177/0192623318809304

Development of a strategy to identify and evaluate direct and indirect activators of constitutive androstane receptor in rats

Takumi Sato, Ryota Shizu, Yoshie Miura, Takuomi Hosaka, Yuichiro Kanno, Takamitsu Sasaki and Kouichi Yoshinari

Food and Chemical Toxicology, 2022, 170, 113510
DOI: 10.1016/j.fct.2022.113510

Update of the risk assessment of polybrominated diphenyl ethers (PBDEs) in food

Dieter Schrenk, Margherita Bignami, Laurent Bodin, James Kevin Chipman, Jesús del Mazo, Bettina Grasl‐Kraupp, Christer Hogstrand, Laurentius (Ron) Hoogenboom, Jean‐Charles Leblanc, Carlo Stefano Nebbia, Elsa Nielsen, Evangelia Ntzani, Annette Petersen, Salomon Sand, Tanja Schwerdtle, Heather Wallace, Diane Benford, Peter Fürst, Andy Hart, Martin Rose, Henri Schroeder, Martine Vrijheid, Sofia Ioannidou, Marina Nikolič, Luisa Ramos Bordajandi and Christiane Vleminckx

EFS2, 2024, 22
DOI: 10.2903/j.efsa.2024.8497

Evaluating the mode of action of perfluorooctanoic acid-induced liver tumors in male Sprague-Dawley rats using a toxicogenomic approach

Xilin Li, Zemin Wang, Qiangen Wu and James E. Klaunig

Journal of Environmental Science and Health, Part C, 2024, 42, 189
DOI: 10.1080/26896583.2024.2327969

Isoflucypram: Combining in vivo and NAMs data in a weight of evidence approach to demonstrate the human non-relevance of the mode of action leading to the subtle thyroid effects observed in the rat

H. Tinwell and R. Bars

Regulatory Toxicology and Pharmacology, 2022, 131, 105154
DOI: 10.1016/j.yrtph.2022.105154

Involvement of Peroxisome Proliferator-Activated Receptor-Alpha in Liver Tumor Production by Permethrin in the Female Mouse

Miwa Kondo, Kaori Miyata, Hirohisa Nagahori, Kayo Sumida, Thomas G Osimitz, Samuel M Cohen, Brian G Lake and Tomoya Yamada

Toxicological Sciences, 2019, 168, 572
DOI: 10.1093/toxsci/kfz012

The potent human CAR activator CITCO is a non-genotoxic hepatic tumour-promoting agent in humanised constitutive androstane receptor mice but not in wild-type animals

C. J. Henderson, A. W. McLaren, A. K. MacLeod, D. Lin, A. R. Cameron, L. R. Chatham, J. Moggs, F. Inesta-Vaquera, John P. Thomson, Richard R. Meehan, P. Chakravarty, M. Schwarz and C. Roland Wolf

Arch Toxicol, 2025, 99, 2197
DOI: 10.1007/s00204-025-03982-9

Metazachlor: Mode of action analysis for rat liver tumour formation and human relevance

Christiane Wiemann, Manuela Goettel, Audrey Vardy, Barbara M. Elcombe, Clifford R. Elcombe, Lynsey R. Chatham, Hongbing Wang, Linhao Li, Roland Buesen, Naveed Honarvar, Silke Treumann, Heike Marxfeld, Sibylle Groeters and Brian G. Lake

Toxicology, 2019, 426, 152282
DOI: 10.1016/j.tox.2019.152282

Mode of action of dieldrin-induced liver tumors: application to human risk assessment

James E. Klaunig and Samuel M. Cohen

Critical Reviews in Toxicology, 2024, 54, 634
DOI: 10.1080/10408444.2024.2377208

Comparison of in vitro thyroxine (T4) metabolism between Wistar rat and human hepatocyte cultures

Audrey Baze, Lucille Wiss, Liliia Horbal, Klaus Biemel, Laure Asselin and Lysiane Richert

Toxicology in Vitro, 2024, 96, 105763
DOI: 10.1016/j.tiv.2023.105763

The Cumulative Risk Assessment of Hepatotoxic Chemicals: A Hepatic Histopathology Perspective

John R. Foster, Giovanna Semino-Beninel and Stephanie Melching-Kollmuss

Toxicol Pathol, 2020, 48, 397
DOI: 10.1177/0192623319895481

An Evaluation of the Human Relevance of the Liver Tumors Observed in Female Mice Treated With Permethrin Based on Mode of Action

Miwa Kondo, Hiroko Kikumoto, Thomas G Osimitz, Samuel M Cohen, Brian G Lake and Tomoya Yamada

Toxicological Sciences, 2020, 175, 50
DOI: 10.1093/toxsci/kfaa017

Response to Letter to the Editor from Drs. van Kesteren, Pronk, Heusinkveld, Luijten and Hakkert concerning Yamada et al. (2021): Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR). Crit. Rev. Toxicol. Vol. 51: 373-394.

Tomoya Yamada, Samuel M. Cohen and Brian G Lake

Critical Reviews in Toxicology, 2022, 52, 399
DOI: 10.1080/10408444.2022.2101915

Mechanisms underlying disruptive effects of pesticides on the thyroid function

Antonio F. Hernández, Susanne H. Bennekou, Andy Hart, Luc Mohimont and Gerrit Wolterink

Current Opinion in Toxicology, 2020, 19, 34
DOI: 10.1016/j.cotox.2019.10.003

Comparative studies on the effects of sodium phenobarbital and two other constitutive androstane receptor (CAR) activators on induction of cytochrome P450 enzymes and replicative DNA synthesis in cultured hepatocytes from wild type and CAR knockout rats

Manuela Goettel, Ivana Fegert, Naveed Honarvar, Audrey Vardy, Corinne Haines, Lynsey R. Chatham and Brian G. Lake

Toxicology, 2020, 433-434, 152394
DOI: 10.1016/j.tox.2020.152394

Gadd45b is required in part for the anti-obesity effect of constitutive androstane receptor (CAR)

Xinran Cai, Ye Feng, Meishu Xu, Chaohui Yu and Wen Xie

Acta Pharmaceutica Sinica B, 2021, 11, 434
DOI: 10.1016/j.apsb.2020.08.015